Flow-Gradient Patterns can help in the selection of patients with aortic stenosis

Original title: Flow-Gradient Patterns in Severe Aortic Stenosis UIT Preserved Ejection Fraction. Clinical Characteristic and Predictos of Survival. Reference: Eleid, M, et al. Circulation 2013;128:1781-1789

Severe aortic stenosis is usually defined by echocardiography as a 40 mm mean transvalvular gradient Hg at >4 m/s; but there are low flow or paradoxical low flow cases with different evolution.

1704 AS patients were divided in 4 groups: low flow/high gradient (LF/HG) n= 50 (3%), low flow/low gradient (LF/LG) n= 53 (3%), normal flow/low gradient (NF/LG) n= 352 (21%) and normal flow/high gradient (NF/HG) n= 1249 (73%).

The less symptomatic was the NF/LG) group, characterized by a high prevalence of women, less, smaller LV cavity and restrictive filling pattern. The LF/LG group presented the most deteriorated LVEF, also the lowest LV mass index, the smallest LV diameter and the greatest incidence of auricular fibrillation.

62% of all patients received surgical AVR and 4% received TAVR. NF/LG patients mostly received medical management, with favorable survival of 59% at 2 years.

The LF/LG group had the worst prognosis, with 60% survival rate at 2 years. Survival rate was 85% for the NF/LG group, 82% for the NF/HG group and 78% for the LF/LG group (p<0.0001 was the difference in survival between groups).  Aortic valve replacement (AVR) was associated with a 69% mortality reduction in LF/LG and NF/HG groups.

Conclusion:

NF/LG severe AS with preserved EF exhibits favorable survival with medical management and impact of AVR on survival was neutral. LF/LG was associated with higher mortality and TAVR was associated with improved survival. 

Editorial Comment

This new way of classifying AS offers important information about prognosis. It would be preferable to start using it on a daily basis, especially with high risk patients that most frequently pose the greatest challenges as regards strategy.

Courtesy of Dr Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. Argentina.

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

ACC 2026 | CHAMPION-AF: Left atrial appendage closure versus anticoagulation in atrial fibrillation

Can left atrial appendage closure challenge anticoagulation as the standard of care in atrial fibrillation? Atrial fibrillation (AF) is the most common sustained arrhythmia and...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...